Lexicon Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth %
- Profit Growth 66.88%
- Ebitda 21.86%
- Net Worth -1.66%
- Total Assets 1.03%
About Lexicon Lifesciences
Lexicon Lifesciences Private Limited (LLPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 December 2009 and has a history of 15 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dhiren Khot and Devika Khot serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2009PTC197870
-
Company No.
197870
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Dec 2009
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Lexicon Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhiren Khot
|
Director | 15-Dec-2009 | Current |
|
Devika Khot
|
Director | 28-May-2018 | Current |
Financial Performance of Lexicon Lifesciences.
Lexicon Lifesciences Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 66.88% increase in profit. The company's net worth dipped by a decrease of 1.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lexicon Lifesciences?
In 2019, Lexicon Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lexicon Chemicals Private LimitedDhiren Khot and Devika Khot are mutual person
-
Beluga Chemicals Private LimitedDhiren Khot is a mutual person
-
Beluga Biozymes Private LimitedDhiren Khot is a mutual person
-
Technion Infrastructure Private Limited
Dhiren Khot and Devika Khot are mutual person
-
Lexicon Infracon Private Limited
Dhiren Khot and Devika Khot are mutual person
-
Beautylity Llp
Devika Khot is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lexicon Lifesciences?
Unlock and access historical data on people associated with Lexicon Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lexicon Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lexicon Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
